-
Je něco špatně v tomto záznamu ?
Genetic Landscape of Amyotrophic Lateral Sclerosis in Czech Patients
D. Baumgartner, Z. Mušová, J. Zídková, P. Hedvičáková, E. Vlčková, L. Joppeková, T. Kramářová, L. Fajkusová, V. Stránecký, J. Geryk, P. Votýpka, R. Mazanec
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články
PubMed
39058450
DOI
10.3233/jnd-230236
Knihovny.cz E-zdroje
- MeSH
- amyotrofická laterální skleróza * genetika MeSH
- DNA vazebné proteiny genetika MeSH
- dospělí MeSH
- expanze repetic DNA * MeSH
- frontotemporální demence * genetika MeSH
- genetická predispozice k nemoci MeSH
- kohortové studie MeSH
- lidé středního věku MeSH
- lidé MeSH
- protein C9orf72 * genetika MeSH
- protein FUS vázající RNA genetika MeSH
- protein-serin-threoninkinasy genetika MeSH
- senioři MeSH
- věk při počátku nemoci MeSH
- vysoce účinné nukleotidové sekvenování MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- Geografické názvy
- Česká republika MeSH
BACKGROUND: Genetic factors are involved in the pathogenesis of familial and sporadic amyotrophic lateral sclerosis (ALS) and constitute a link to its association with frontotemporal dementia (FTD). Gene-targeted therapies for some forms of ALS (C9orf72, SOD1) have recently gained momentum. Genetic architecture in Czech ALS patients has not been comprehensively assessed so far. OBJECTIVE: We aimed to deliver pilot data on the genetic landscape of ALS in our country. METHODS: A cohort of patients with ALS (n = 88), recruited from two Czech Neuromuscular Centers, was assessed for hexanucleotide repeat expansion (HRE) in C9orf72 and also for genetic variations in other 36 ALS-linked genes via next-generation sequencing (NGS). Nine patients (10.1%) had a familial ALS. Further, we analyzed two subgroups of sporadic patients - with concomitant FTD (n = 7) and with young-onset of the disease (n = 22). RESULTS: We detected the pathogenic HRE in C9orf72 in 12 patients (13.5%) and three other pathogenic variants in FUS, TARDBP and TBK1, each in one patient. Additional 7 novel and 9 rare known variants with uncertain causal significance have been detected in 15 patients. Three sporadic patients with FTD (42.9%) were harbouring a pathogenic variant (all HRE in C9orf72). Surprisingly, none of the young-onset sporadic patients harboured a pathogenic variant and we detected no pathogenic SOD1 variant in our cohort. CONCLUSION: Our findings resemble those from other European populations, with the highest prevalence of HRE in the C9orf72 gene. Further, our findings suggest a possibility of a missing genetic variability among young-onset patients.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24020027
- 003
- CZ-PrNML
- 005
- 20241024110925.0
- 007
- ta
- 008
- 241015s2024 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3233/JND-230236 $2 doi
- 035 __
- $a (PubMed)39058450
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Baumgartner, Daniel $u Department of Neurology, Neuromuscular Center, Charles University, 2nd Faculty of Medicine and University Hospital Motol, Prague, Czech Republic
- 245 10
- $a Genetic Landscape of Amyotrophic Lateral Sclerosis in Czech Patients / $c D. Baumgartner, Z. Mušová, J. Zídková, P. Hedvičáková, E. Vlčková, L. Joppeková, T. Kramářová, L. Fajkusová, V. Stránecký, J. Geryk, P. Votýpka, R. Mazanec
- 520 9_
- $a BACKGROUND: Genetic factors are involved in the pathogenesis of familial and sporadic amyotrophic lateral sclerosis (ALS) and constitute a link to its association with frontotemporal dementia (FTD). Gene-targeted therapies for some forms of ALS (C9orf72, SOD1) have recently gained momentum. Genetic architecture in Czech ALS patients has not been comprehensively assessed so far. OBJECTIVE: We aimed to deliver pilot data on the genetic landscape of ALS in our country. METHODS: A cohort of patients with ALS (n = 88), recruited from two Czech Neuromuscular Centers, was assessed for hexanucleotide repeat expansion (HRE) in C9orf72 and also for genetic variations in other 36 ALS-linked genes via next-generation sequencing (NGS). Nine patients (10.1%) had a familial ALS. Further, we analyzed two subgroups of sporadic patients - with concomitant FTD (n = 7) and with young-onset of the disease (n = 22). RESULTS: We detected the pathogenic HRE in C9orf72 in 12 patients (13.5%) and three other pathogenic variants in FUS, TARDBP and TBK1, each in one patient. Additional 7 novel and 9 rare known variants with uncertain causal significance have been detected in 15 patients. Three sporadic patients with FTD (42.9%) were harbouring a pathogenic variant (all HRE in C9orf72). Surprisingly, none of the young-onset sporadic patients harboured a pathogenic variant and we detected no pathogenic SOD1 variant in our cohort. CONCLUSION: Our findings resemble those from other European populations, with the highest prevalence of HRE in the C9orf72 gene. Further, our findings suggest a possibility of a missing genetic variability among young-onset patients.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a amyotrofická laterální skleróza $x genetika $7 D000690
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 12
- $a protein C9orf72 $x genetika $7 D000073885
- 650 _2
- $a senioři $7 D000368
- 650 12
- $a expanze repetic DNA $7 D042622
- 650 _2
- $a dospělí $7 D000328
- 650 12
- $a frontotemporální demence $x genetika $7 D057180
- 650 _2
- $a protein FUS vázající RNA $x genetika $7 D034702
- 650 _2
- $a kohortové studie $7 D015331
- 650 _2
- $a DNA vazebné proteiny $x genetika $7 D004268
- 650 _2
- $a protein-serin-threoninkinasy $x genetika $7 D017346
- 650 _2
- $a věk při počátku nemoci $7 D017668
- 650 _2
- $a genetická predispozice k nemoci $7 D020022
- 650 _2
- $a vysoce účinné nukleotidové sekvenování $7 D059014
- 651 _2
- $a Česká republika $7 D018153
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Mušová, Zuzana $u Department of Biology and Medical Genetics, Charles University, 2nd Faculty of Medicine and University Hospital Motol, Prague, Czech Republic
- 700 1_
- $a Zídková, Jana $u Center for Molecular Biology and Genetics, Internal Haematology and Oncology Clinic, University Hospital Brno and Faculty of Medicine, Masaryk University Brno, Czech Republic
- 700 1_
- $a Hedvičáková, Petra $u Department of Biology and Medical Genetics, Charles University, 2nd Faculty of Medicine and University Hospital Motol, Prague, Czech Republic
- 700 1_
- $a Vlčková, Eva $u Department of Neurology, Neuromuscular Center, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Joppeková, Lubica $u Department of Neurology, Neuromuscular Center, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Kramářová, Tereza $u Center for Molecular Biology and Genetics, Internal Haematology and Oncology Clinic, University Hospital Brno and Faculty of Medicine, Masaryk University Brno, Czech Republic
- 700 1_
- $a Fajkusová, Lenka $u Center for Molecular Biology and Genetics, Internal Haematology and Oncology Clinic, University Hospital Brno and Faculty of Medicine, Masaryk University Brno, Czech Republic
- 700 1_
- $a Stránecký, Viktor $u Department of Pediatrics and Inherited Metabolic Disorders, Research Unit for Rare Diseases, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czech Republic
- 700 1_
- $a Geryk, Jan $u Department of Biology and Medical Genetics, Charles University, 2nd Faculty of Medicine and University Hospital Motol, Prague, Czech Republic
- 700 1_
- $a Votýpka, Pavel $u Department of Biology and Medical Genetics, Charles University, 2nd Faculty of Medicine and University Hospital Motol, Prague, Czech Republic
- 700 1_
- $a Mazanec, Radim $u Department of Neurology, Neuromuscular Center, Charles University, 2nd Faculty of Medicine and University Hospital Motol, Prague, Czech Republic
- 773 0_
- $w MED00195037 $t Journal of neuromuscular diseases $x 2214-3602 $g Roč. 11, č. 5 (2024), s. 1035-1048
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39058450 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20241015 $b ABA008
- 991 __
- $a 20241024110919 $b ABA008
- 999 __
- $a ok $b bmc $g 2202325 $s 1232000
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 11 $c 5 $d 1035-1048 $e - $i 2214-3602 $m Journal of neuromuscular diseases $n J Neuromuscul Dis $x MED00195037
- LZP __
- $a Pubmed-20241015